Clinical translation
with
1000s
of patients

MoveMed is redefining how outcomes are measured in clinical trials. This patented approach enables much smaller, faster and cost-effective trials without compromising scientific rigor, unlocking the key bottleneck in drug discovery.

Movemed
UNIVERSITY OF CAMBRIDGE
AMAZON
NHS
THE UNIVERSITY OF SYDNEY
British Association of Spine Surgeons
MEDICINOVA
NYU LANGONE HEALTH
National Institute for Health Research
MYELOPATHY.org
UNIVERSITY OF CAMBRIDGE
AMAZON
NHS
THE UNIVERSITY OF SYDNEY
British Association of Spine Surgeons
MEDICINOVA
NYU LANGONE HEALTH
National Institute for Health Research
MYELOPATHY.org

Patient voice +
biomarker power

To develop a drug successfully, it's crucial to demonstrate real patient benefit. Patient-reported outcomes (PROs) are the gold standard but require large sample sizes and may miss key effects, leading to false negatives.

That's why early studies often use biomarkers, though these can also fail to capture the patient experience, potentially leading to false positives.

MoveMed’s breakthrough is to offer both.

Patiente Voice Biomarker

Get the Most Advanced Approach
to Patient Measurement

Our method allows us to avoid false dawns and missed opportunities. Through its mobile application MoveMed encourages patients to complete and interpret digital performance measures, preserving the patient’s “voice” while delivering the statistical power of a biomarker:

Get the most advanced approach

Patient Reported

Our tests directly assess patient experience; the patient voice - we are not measuring a surrogate of this (e.g. a blood test). Completed remotely and at their convenience, this provides real-life measurement even if a disease is variable.

Multi-Construct

With assessments covering multiple features (e.g., hand and leg function), we gather a comprehensive insight, and ensure even if one area shows limited change, gains in another are identified.

Higher Compliance and Less Missing Data

Digital assessments encourage completion, and centralized monitoring enables direct patient engagement to ensure compliance. This minimizes missing data, supporting consistent and reliable results.

More Reliable with Earlier Insights

Frequent testing allows results to be averaged, reducing the impact of outliers or single erroneous readings. With built-in quality checks, MoveMed ensures patient data is accurate, complete, and reliable—addressing common PRO challenges.

Statistically Powerful

Our assessments are granular and reliable, offering far greater statistical power. This reduces the patient numbers needed for reliable results—either as a primary outcome, or a powerful tool for patient stratification to identify treatment responders.

What is the trial workflow?

Trial Setup and Patient Recruitment

Trial Setup and Patient Recruitment

Patient Setup with MoveMed

Patient Setup with MoveMed

Data Collection and Engagement

Data Collection and Engagement

Data Monitoring and Management

Data Monitoring and Management

Final Assessments and Trial Completion

Final Assessments and Trial Completion

Data Analysis Support (Optional)

What is the trial workflow?

Trial Setup and Patient Recruitment

Trial Setup and Patient Recruitment

Patient Setup with MoveMed

Patient Setup with MoveMed

Data Collection and Engagement

Data Monitoring and Management

Data Monitoring and Management

Final Assessments and Trial Completion

Final Assessments and Trial Completion

Data Analysis Support - Optional

Data Analysis Support (Optional)

We offer additional tools to enhance recruitment, data collection, and oversight

We offer additional tools to enhance recruitment, data collection, and oversight

Available globally on both Apple and Android devices,
and in multiple languages, expanding eligibility and accessibility for diverse patient populations.

Integrates with operating system health measures
like Google Fit and Apple HealthKit for enriched data collection.

Allows deployment of custom electronic PROs
to capture tailored patient-reported outcomes.

Provides a real-time dashboard

Provides a real-time dashboard
for monitoring recruitment progress and data compliance, ensuring a smooth and reliable trial experience.

Our clients say

MoveMed enabled us to assess end-points remotely and helped with patient engagement. Of course, PerfOMs have significant potential, and I am excited to see the outcome of a direct comparison with a clinical gold standard. The gamified assessments helped with patient engagement and verbally patients supported the use of the app and liked the feedback given. The smartphone-based approach was convenient for patients and researchers.

UNIVERSITY OF CAMBRIDGE
Stefan Yordanov

Dr. Stefan Yordanov

Research clinical fellow and Specialty registrar in Neurosurgery at Cambridge University Hospitals NHS Foundation Trust

MoveMed is a great tool to use for research. The interface was easy to navigate and made data collection simple. The exported MoveMed data contained relevant outcome measures crucial for data analysis. It was a great experience using MoveMed and would highly recommend it to all researchers!

THE UNIVERSITY OF SYDNEY
Maggie Li

Maggie Li

University of Sydney

The app made it incredibly convenient to contribute to Myelopathy research from the comfort of my home. The assessments felt like playing a game, which kept me engaged and motivated to continue over time. It was a great feeling to know that my data could potentially contribute to advancing research.

MYELOPATHY.org
Iwan Sadler

Iwan Sadler

Co-Founder and Trustee of Myelopathy.org
Living with DCM

MoveMed enabled us to assess end-points remotely and helped with patient engagement. Of course, PerfOMs have significant potential, and I am excited to see the outcome of a direct comparison with a clinical gold standard. The gamified assessments helped with patient engagement and verbally patients supported the use of the app and liked the feedback given. The smartphone-based approach was convenient for patients and researchers.

UNIVERSITY OF CAMBRIDGE
Stefan Yordanov

Dr. Stefan Yordanov

Research clinical fellow and Specialty registrar in Neurosurgery at Cambridge University Hospitals NHS Foundation Trust

MoveMed is a great tool to use for research. The interface was easy to navigate and made data collection simple. The exported MoveMed data contained relevant outcome measures crucial for data analysis. It was a great experience using MoveMed and would highly recommend it to all researchers!

THE UNIVERSITY OF SYDNEY
Maggie Li

Maggie Li

University of Sydney

The app made it incredibly convenient to contribute to Myelopathy research from the comfort of my home. The assessments felt like playing a game, which kept me engaged and motivated to continue over time. It was a great feeling to know that my data could potentially contribute to advancing research.

MYELOPATHY.org
Iwan Sadler

Iwan Sadler

Co-Founder and Trustee of Myelopathy.org
Living with DCM

The product is in use

MoveMed is a Patient Centred Innovation

MoveMed is a Patient Centred Innovation

MoveMed in Clinical Trials: Advancing Research in Degenerative Cervical Myelopathy

MoveMed in Clinical Trials: Advancing Research in Degenerative Cervical Myelopathy

MoveMed Valid and Reliable for Degenerative Cervical Myelopathy

MoveMed Valid and Reliable for Degenerative Cervical Myelopathy

Get started with MoveMed

Find out how our product will improve your research